MJNews / PR Newswire

OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model

Breavix was designed to support oncological journey of breast cancer patients,  have been tested in several preclinical studies, and will be sold in California soon.  At OncoRix.com, patients can register to participate the trial and integrate Breavix with chemotherapy. (PRNewsfoto/Cannabotech)
OncoRix’s breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model OncoRix’s breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model PR Newswire HERZLIYA, Israel, March 30, 2024 The ex-vivo model is based on a unique technology developed at the Weizmann Institute, and it … Continue reading ""

One thought on “MJNews / PR Newswire”

Leave a Reply

Your email address will not be published. Required fields are marked *